Baseline characteristics associated with PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19) Meeting Abstract


Authors: Aggarwal, R. R.; Heller, G.; Hillman, D. W.; Xiao, H.; Picus, J.; Taplin, M. E.; Dorff, T. B.; Appleman, L. J.; Weckstein, D. J.; Patnaik, A.; Bryce, A. H.; Shevrin, D. H.; Mohler, J.; Anderson, D. M.; Rao, A.; Tagawa, S. T.; Tan, A.; Eggener, S. E.; Ryan, C. J.; Morris, M. J.
Abstract Title: Baseline characteristics associated with PSA progression-free survival in patients (pts) with high-risk biochemically relapsed prostate cancer: Results from the phase 3 PRESTO study (AFT-19)
Meeting Title: 2023 ASCO Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 41
Issue: 6 Suppl.
Meeting Dates: 2023 Feb 16-18
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2023-02-20
Language: English
DOI: 10.1200/JCO.2023.41.6_suppl.208
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting abstract: 208 -- Accession Number: 162006479 -- Entry Date: In Process -- Revision Date: 20230223 -- Publication Type: Article -- Supplement Title: 2/21/2023 Supplement -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 8309333. -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Glenn Heller
    399 Heller
  2. Han Xiao
    59 Xiao
  3. Michael Morris
    577 Morris